Serum antimüllerian hormone levels are independently related to miscarriage rates after in vitro fertilization–embryo transfer

Regardless of age and ovarian response to controlled ovarian stimulation, serum anti-m€ullerian hormone levels are associated with miscarriage rates following in vitro fertilization–embryo transfer.

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment

Volume 108, Issue 3, Pages 518–524

Authors:

Bruno Tarasconi, M.D., Teddy Tadros, M.D., Jean-Marc Ayoubi, M.D., Ph.D., Stephanie Belloc, Pharm.D., Dominique de Ziegler, M.D., Renato Fanchin, M.D., Ph.D.

Abstract:

Objective

To investigate whether serum antimüllerian hormone (AMH) levels are independently related to miscarriage rates after in vitro fertilization–embryo transfer (IVF-ET).

Design

Cohort study.

Setting

University-affiliated IVF-ET center.

Patient(s)

A total of 1,060 patients who attained a clinical pregnancy after IVF-ET.

Interventions(s)

Centralized serum AMH measurements were performed within the 12 months before IVF-ET. Binary logistic regression was used to verify whether serum AMH levels were associated with the occurrence of a miscarriage independently from confounding factors, such as age and intensity of ovarian response to controlled ovarian stimulation assessed by the number of oocytes retrieved.

Main Outcome Measure(s)

Miscarriage rates.

Result(s)

In patients displaying reduced serum AMH levels, miscarriage rates were significantly increased independently from age and the number of oocytes retrieved.

Conclusion(s)

The present data indicate that serum AMH levels are independently associated with the occurrence of a miscarriage after IVF-ET.


Read the full text here.


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

Comments

Go to the profile of Alexander Quaas
Alexander Quaas
over 3 years ago

This interesting study would suggest that in two women of the same age undergoing ART treatments, the one with the lower AMH level has the higher miscarriage risk.

Can the authors expand on the biological plausibility of this? In the paper, the underlying mechanism for the findings is thought to be "that lower serum AMH levels also reflect a relatively deficient

AMH production by unhealthy follicles that contain an incompetent oocyte".

Can we really extrapolate from the production of a hormone by the totality of antral follicle granulosa cells at baseline to the quality (and maybe even genetic status) of a cohort of oocytes at the end of stimulation? If yes is there more than empiric evidence for a biologic mechanism?